SGMTSagimet Biosciences Inc.

$8.91+21% 1Y

The financials

Sagimet Biosciences Inc. by the numbers

The next results filing is expected around Nov 12, 2026, the same week as a year ago.

Sagimet Biosciences Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$16M−$12Mn/a
Net income−$14M−$10Mn/a
Diluted EPS−$0.26−$0.32n/a